Dong-E-E-Jiao Co Ltd
SZSE:000423
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
45.21
71.59
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Dong-E-E-Jiao Co Ltd
Dong-E-E-Jiao Co Ltd
Other Long-Term Assets
Dong-E-E-Jiao Co Ltd
Other Long-Term Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Dong-E-E-Jiao Co Ltd
SZSE:000423
|
Other Long-Term Assets
¥305.2m
|
CAGR 3-Years
9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
20%
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Other Long-Term Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Other Long-Term Assets
¥215.7m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Other Long-Term Assets
¥702.3m
|
CAGR 3-Years
24%
|
CAGR 5-Years
25%
|
CAGR 10-Years
33%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Other Long-Term Assets
¥928.6m
|
CAGR 3-Years
15%
|
CAGR 5-Years
12%
|
CAGR 10-Years
19%
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Other Long-Term Assets
¥84.9m
|
CAGR 3-Years
16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Dong-E-E-Jiao Co Ltd
Glance View
In the heart of China's Shandong Province lies Dong-E-E-Jiao Co Ltd, a company deeply rooted in the traditions of Chinese medicinal culture yet driven by the dynamics of a modern corporation. Established in the early 1950s, Dong-E-E-Jiao takes its name from its primary product, "ejiao," a traditional medicine derived from donkey-hide gelatin. Traditionally used in Chinese medicine for its purported benefits in nourishing blood and enhancing vitality, ejiao forms the cornerstone of Dong-E-E-Jiao's product line. At the company’s state-of-the-art facilities, these gelatin products are manufactured with a blend of time-tested practices and contemporary techniques, ensuring quality and efficacy that cater to both domestic and international markets. Dong-E-E-Jiao’s approach to business revolves around harnessing the age-old wisdom of Chinese medicine, coupled with a solid understanding of global health and wellness trends. Beyond gelatin products, the company has diversified into related segments, offering nutritional supplements, beauty products, and contemporary health foods—all linked by their heritage in traditional Chinese medicine. This diversification strategy has opened multiple revenue streams, allowing Dong-E-E-Jiao to expand its market reach while anchoring its brand in authenticity and trust. Sales are driven through a mix of direct retail channels, partnerships with pharmacies, and an increasing online presence, ensuring that their products remain accessible to a broad array of consumers. In this way, Dong-E-E-Jiao balances the dual imperatives of tradition and innovation to drive its business forward.
See Also
What is Dong-E-E-Jiao Co Ltd's Other Long-Term Assets?
Other Long-Term Assets
305.2m
CNY
Based on the financial report for Sep 30, 2024, Dong-E-E-Jiao Co Ltd's Other Long-Term Assets amounts to 305.2m CNY.
What is Dong-E-E-Jiao Co Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
20%
Over the last year, the Other Long-Term Assets growth was -1%. The average annual Other Long-Term Assets growth rates for Dong-E-E-Jiao Co Ltd have been 9% over the past three years , 7% over the past five years , and 20% over the past ten years .
You don't have any saved screeners yet
